ExodusPoint Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-311,337
| Closed | -$13.3M | – | 1553 |
|
|
2024
Q1 | $13.3M | Buy |
311,337
+74,528
| +31% | +$3.2M | 0.1% | 131 |
|
|
2023
Q4 | $8.78M | Sell |
236,809
-62,488
| -21% | -$2.32M | 0.06% | 192 |
|
|
2023
Q3 | $10.9M | Buy |
299,297
+281,082
| +1,543% | +$10.2M | 0.1% | 178 |
|
|
2023
Q2 | $649K | Buy |
+18,215
| New | +$649K | 0.01% | 1172 |
|
|
2023
Q1 | – | Sell |
-280,187
| Closed | -$9.85M | – | 1800 |
|
|
2022
Q4 | $9.85M | Buy |
280,187
+30,029
| +12% | +$1.06M | 0.14% | 162 |
|
|
2022
Q3 | $7.36M | Buy |
250,158
+112,632
| +82% | +$3.31M | 0.1% | 269 |
|
|
2022
Q2 | $7.48M | Buy |
137,526
+113,010
| +461% | +$6.15M | 0.09% | 255 |
|
|
2022
Q1 | $1.34M | Sell |
24,516
-163
| -0.7% | -$8.88K | 0.02% | 927 |
|
|
2021
Q4 | $1.36M | Sell |
24,679
-7,321
| -23% | -$403K | 0.01% | 885 |
|
|
2021
Q3 | $1.53M | Sell |
32,000
-12,462
| -28% | -$595K | 0.02% | 799 |
|
|
2021
Q2 | $2.21M | Buy |
+44,462
| New | +$2.21M | 0.02% | 586 |
|
|
2021
Q1 | – | Sell |
-49,346
| Closed | -$2.27M | – | 2234 |
|
|
2020
Q4 | $2.27M | Buy |
49,346
+38,552
| +357% | +$1.77M | 0.02% | 465 |
|
|
2020
Q3 | $508K | Buy |
+10,794
| New | +$508K | 0.01% | 952 |
|
|
2019
Q3 | – | Sell |
-5,040
| Closed | -$252K | – | 1417 |
|
|
2019
Q2 | $252K | Sell |
5,040
-10,500
| -68% | -$525K | 0.01% | 760 |
|
|
2019
Q1 | $812K | Buy |
+15,540
| New | +$812K | 0.06% | 219 |
|